Cargando…
Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation
BACKGROUND: Military personnel in enclosed societies are at increased risk of respiratory infections. We investigated an outbreak of Coronavirus Disease 2019 in a London Army barracks early in the pandemic. METHODS: Army personnel, their families and civilians had nasal and throat swabs for Severe A...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834392/ https://www.ncbi.nlm.nih.gov/pubmed/33870245 http://dx.doi.org/10.1016/j.lanepe.2020.100015 |
_version_ | 1783642271001870336 |
---|---|
author | Taylor, Hannah Wall, William Ross, David Janarthanan, Roshni Wang, Liyang Aiano, Felicity Ellis, Joanna Gopal, Robin Andrews, Nick Patel, Monika Lackenby, Angie Myers, Richard Ramsay, Mary E Chow, J. Yimmy Zambon, Maria Ladhani, Shamez N |
author_facet | Taylor, Hannah Wall, William Ross, David Janarthanan, Roshni Wang, Liyang Aiano, Felicity Ellis, Joanna Gopal, Robin Andrews, Nick Patel, Monika Lackenby, Angie Myers, Richard Ramsay, Mary E Chow, J. Yimmy Zambon, Maria Ladhani, Shamez N |
author_sort | Taylor, Hannah |
collection | PubMed |
description | BACKGROUND: Military personnel in enclosed societies are at increased risk of respiratory infections. We investigated an outbreak of Coronavirus Disease 2019 in a London Army barracks early in the pandemic. METHODS: Army personnel, their families and civilians had nasal and throat swabs for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcriptase -polymerase chain reaction (RT-PCR), virus isolation and whole genome sequencing, along with blood samples for SARS-CoV-2 antibodies. All tests were repeated 36 days later. FINDINGS: During the first visit, 304 (254 Army personnel, 10 family members, 36 civilians, 4 not stated) participated and 24/304 (8%) were SARS-CoV-2 RT-PCR positive. Infectious virus was isolated from 7/24 (29%). Of the 285 who provided a blood sample, 7% (19/285) were antibody positive and 63% (12/19) had neutralising antibodies. Twenty-two (22/34, 64%) individuals with laboratory-confirmed infection were asymptomatic. Nine SARS-CoV-2 RT-PCR positive participants were also antibody positive but those who had neutralising antibodies did not have infectious virus. At the second visit, no new infections were detected, and 13% (25/193) were seropositive, including 52% (13/25) with neutralising antibodies. Risk factors for SARS-CoV-2 antibody positivity included contact with a confirmed case (RR 25.2; 95% CI 14–45), being female (RR 2.5; 95% CI 1.0–6.0) and two-person shared bathroom (RR 2.6; 95% CI 1.1–6.4). INTERPRETATION: We identified high rates of asymptomatic SARS-CoV-2 infection. Public Health control measures can mitigate spread but virus re-introduction from asymptomatic individuals remains a risk. Most seropositive individuals had neutralising antibodies and infectious virus was not recovered from anyone with neutralising antibodies. FUNDING: PHE |
format | Online Article Text |
id | pubmed-7834392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-78343922021-01-26 Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation Taylor, Hannah Wall, William Ross, David Janarthanan, Roshni Wang, Liyang Aiano, Felicity Ellis, Joanna Gopal, Robin Andrews, Nick Patel, Monika Lackenby, Angie Myers, Richard Ramsay, Mary E Chow, J. Yimmy Zambon, Maria Ladhani, Shamez N Lancet Reg Health Eur Research Paper BACKGROUND: Military personnel in enclosed societies are at increased risk of respiratory infections. We investigated an outbreak of Coronavirus Disease 2019 in a London Army barracks early in the pandemic. METHODS: Army personnel, their families and civilians had nasal and throat swabs for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcriptase -polymerase chain reaction (RT-PCR), virus isolation and whole genome sequencing, along with blood samples for SARS-CoV-2 antibodies. All tests were repeated 36 days later. FINDINGS: During the first visit, 304 (254 Army personnel, 10 family members, 36 civilians, 4 not stated) participated and 24/304 (8%) were SARS-CoV-2 RT-PCR positive. Infectious virus was isolated from 7/24 (29%). Of the 285 who provided a blood sample, 7% (19/285) were antibody positive and 63% (12/19) had neutralising antibodies. Twenty-two (22/34, 64%) individuals with laboratory-confirmed infection were asymptomatic. Nine SARS-CoV-2 RT-PCR positive participants were also antibody positive but those who had neutralising antibodies did not have infectious virus. At the second visit, no new infections were detected, and 13% (25/193) were seropositive, including 52% (13/25) with neutralising antibodies. Risk factors for SARS-CoV-2 antibody positivity included contact with a confirmed case (RR 25.2; 95% CI 14–45), being female (RR 2.5; 95% CI 1.0–6.0) and two-person shared bathroom (RR 2.6; 95% CI 1.1–6.4). INTERPRETATION: We identified high rates of asymptomatic SARS-CoV-2 infection. Public Health control measures can mitigate spread but virus re-introduction from asymptomatic individuals remains a risk. Most seropositive individuals had neutralising antibodies and infectious virus was not recovered from anyone with neutralising antibodies. FUNDING: PHE Elsevier 2020-12-21 /pmc/articles/PMC7834392/ /pubmed/33870245 http://dx.doi.org/10.1016/j.lanepe.2020.100015 Text en Crown Copyright © 2020 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Taylor, Hannah Wall, William Ross, David Janarthanan, Roshni Wang, Liyang Aiano, Felicity Ellis, Joanna Gopal, Robin Andrews, Nick Patel, Monika Lackenby, Angie Myers, Richard Ramsay, Mary E Chow, J. Yimmy Zambon, Maria Ladhani, Shamez N Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation |
title | Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation |
title_full | Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation |
title_fullStr | Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation |
title_full_unstemmed | Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation |
title_short | Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation |
title_sort | cross sectional investigation of a covid-19 outbreak at a london army barracks: neutralising antibodies and virus isolation |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834392/ https://www.ncbi.nlm.nih.gov/pubmed/33870245 http://dx.doi.org/10.1016/j.lanepe.2020.100015 |
work_keys_str_mv | AT taylorhannah crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT wallwilliam crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT rossdavid crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT janarthananroshni crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT wangliyang crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT aianofelicity crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT ellisjoanna crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT gopalrobin crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT andrewsnick crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT patelmonika crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT lackenbyangie crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT myersrichard crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT ramsaymarye crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT chowjyimmy crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT zambonmaria crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation AT ladhanishamezn crosssectionalinvestigationofacovid19outbreakatalondonarmybarracksneutralisingantibodiesandvirusisolation |